Efficacy of mesenchymal stem cell-delivery using perpendicular multi-needle injections to the skin: Evaluation of post-ejection cellular health and dermal delivery.
Rangatchew F., Rasmussen BS., Svalgaard JD., Haastrup E., Talman MM., Bonde C.
Clinical Trial on Burns, published in Burns (2022) — summary generated from the PubMed abstract.
Several human studies show positive signals, while research methods and sample sizes continue to develop.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Clinical Trial
- Journal
- Burns (2022)
- Country
- Netherlands
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 35618513
- DOI
- 10.1016/j.burns.2022.04.020
- Citations
- 1
Abstract (original English)
Aim Mesenchymal stem cell (MSC)-therapy is increasingly being evaluated in clinical trials. Dermal delivery is not only time consuming but also unreliable, potentially hampering the therapeutic result. Therefore, qualification of cell delivery protocols is essential. This study evaluated a clinically relevant automated multi-needle injection method for cutaneous MSC-therapy, allowing the skin to be readily and timely treated, by assessing both the cellular health post-ejection and dermal delivery. Methods Following dispensation through the injector (31 G needles: 9- or 5-pin) the cellular health and potency (perceived- and long-term (12 h) viability, recovery, metabolism, adherence, proliferation and IDO1-expression) of adipose-derived stem cells (10-20-50 ×10 6 cells/ml) were assessed in vitro in addition to dermal delivery of solution in human skin. Results No significant detrimental effect on the perceived cell viability, recovery, metabolism, adherence or IDO1-expression of either cell concentration was observed. However, the overall long-term viability and proliferation decreased significantly regardless of cell concentration, nonetheless marginally. An injection depth above 1.0 mm resulted in all needles piercing the skin with dermal delivery from up to 89% needles and minimal reflux to the skin surface, and the results were confirmed by ultrasound and histology. Conclusi
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Several human studies show positive signals, while research methods and sample sizes continue to develop.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Platelet-rich plasma and ablative fractional carbon dioxide laser therapy for chronic scar management: a systematic review
Systematic Review with a reported sample of 420 on Burns, Scar, published in Lasers Med Sci (2026) — summary generated from the PubMed abstract.
- 2026
- n = 420
Lasers Med Sci - Level ASystematic ReviewEurope PMC
Mesenchymal Stem Cell-Derived Extracellular Vesicles and Plant-Derived Nanovesicles as Cell-Free Therapies for Thermal Burn Healing: A Systematic Review of Preclinical Evidence and Delivery Strategies
Systematic Review on Chronic Wound, Burns, Scar, Chronic Inflammation, published in Med Sci (Basel) (2026) — summary generated from the PubMed abstract.
- 2026
Med Sci (Basel) - Level ASystematic ReviewPubMed
Autologous Nanofat Indications in Wound Healing: A Systematic Review.
Systematic Review with a reported sample of 3 on Chronic Wound, Burns, Scar, published in Biomedicines (2026) — summary generated from the PubMed abstract.
- 2026
- n = 3
Biomedicines - Level AMeta-analysisEurope PMC
Systematic review and meta-analysis of the use of micrografting technology in humans
Meta-analysis with a reported sample of 24 on Chronic Wound, Burns, Hair Loss, published in J Int Med Res (2025) — summary generated from the PubMed abstract.
- 2025
- n = 24
J Int Med Res1 citations - Level ASystematic ReviewPubMed
Encapsulation of Adipose-Derived Stem Cells in Collagen-Based Hydrogel: Regenerative Therapy for Burn Wound Healing.
Systematic Review on Chronic Wound, Burns, Scar, published in Ann Plast Surg (2025) — summary generated from the PubMed abstract.
- 2025
Ann Plast Surg - Level AMeta-analysisEurope PMC
Synergistic effects of mesenchymal stem cells and their secretomes with scaffolds in burn wound healing: a systematic review and meta-analysis of preclinical studies
Meta-analysis on Chronic Wound, Burns, Scar, Chronic Inflammation, published in J Transl Med (2025) — summary generated from the PubMed abstract.
- 2025
J Transl Med11 citations